108906-66-7 Usage
Description
(1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~ is a complex organic compound characterized by its numerous hydroxyl groups and a cyclic structure. It features a dihydroxyphenyl group and a chromen-8-yl group, and the molecule is highly oxygenated, with a significant number of hydroxyl and oxo (oxygen) groups. (1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~'s structure is unusual and intricate, with a large number of carbon atoms and a complex arrangement of functional groups.
Uses
Used in Pharmaceutical Industry:
(1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~ is used as a pharmaceutical candidate for various applications due to its complex structure and numerous functional groups, which may have potential therapeutic effects.
Used in Drug Delivery Systems:
(1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~ can be used in drug delivery systems to improve the delivery, bioavailability, and therapeutic outcomes of other pharmaceutical agents. Its complex structure and numerous hydroxyl groups may allow for the development of novel drug carriers and delivery mechanisms.
Used in Chemical Research:
(1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~ can be used in chemical research to study the properties and behavior of complex organic compounds, as well as to develop new synthetic methods and applications for similar molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 108906-66-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,9,0 and 6 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 108906-66:
(8*1)+(7*0)+(6*8)+(5*9)+(4*0)+(3*6)+(2*6)+(1*6)=137
137 % 10 = 7
So 108906-66-7 is a valid CAS Registry Number.
108906-66-7Relevant articles and documents
Tannins and Related Compounds. LXXII. Isolation and Characterisation of Mongolicanin (Procyanidino-ellagitannin), Mongolinin A, Acutissimin C and Vescalagin Carboxylic Acid, Novel Tannins from Quercus mongolica var. grosseserrata
Ishimaru, Kanji,Ishimatsu, Makoto,Nonaka, Gen-Ichiro,Mihashi, Kunihide,Iwase, Yukiko,Nishioka, Itsuo
, p. 3319 - 3327 (2007/10/02)
A novel procyanidino-ellagitannin, mongolicanin (1), has been isolated, together with free new tannins, mongolinin A (4), acutissimin C (7) and vescalagin carboxylic acid (8), from the bark of Quercus mongolica var. grosseserrata (Fagaceae), and the structures of these compounds were established on the basis of physicochemical data.Keywords--Quercus mongolica var. grosseserrata; Fagaceae; mongolicanin; procyanidino-ellagitannin; mongolinin A; acutissimin C; vescalagin carboxylic acid; flavano-ellagitannin; C-glycosylated ellagitannin; open-chain-form glucose
